Adocia lance une étude clinique de Phase 1b de trois semaines avec ADO09, une coformulation de pramlintide et d’une insuline prandiale, chez des sujets diabétiques de type 1
ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.